Tel：
(86)(21)60969600
Add: Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
Shanghai, China – Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort EP") recently obtained the regulatory approval from China Food and Drug Administration ("CFDA") for its in-house developed EasyFinder™ 3D Steerable curve mapping catheter.
The EasyFinder™ 3D catheter is indicated for use in cardiac electrophysioloty studies. When used with Columbus™ 3D EP Navigation System ("Columbus™") and External Reference Patch, it provides precise location of the catheter curve in the body. EasyFinder™ 3D catheter has a high-torque shaft with a deflectable curve section. The tip deflection is controlled at the proximal end by a handle. The high-torque shaft also allows the plane of the curved tip to be rotated to facilitate accurate positioning of the catheter tip at the desired site.
President of MicroPort EP Yiyong Sun said: "The CFDA approval of EasyFinder™ 3D Steerable curve mapping catheter signifies a major step forward for MicroPort EP to provide a complete electrophysiological solution for arrhythmia patients with combinations of active and passive devices and equipment."
